CEO
R
RudaCure
RudaCure develops targeted therapeutics for incurable diseases, utilizing proprietary drug discovery methods to identify and optimize small molecule inhibitors. The company focuses on addressing unmet medical needs in conditions such as ocular surface diseases, where existing treatments are insufficient.
- Biotechnology
Updated 7 months ago
Funding
Raised to date
$300KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- RudaCure develops targeted therapeutics for incurable diseases, utilizing proprietary drug discovery methods to identify and optimize small molecule inhibitors. The company focuses on addressing unmet medical needs in conditions such as ocular surface diseases, where existing treatments are insufficient.